A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 9/16 (2006.01) A61K 9/20 (2006.01)
Patent
CA 2641451
A pharmaceutical composition comprises (a) a CETP inhibiting compound, or a pharmaceutically acceptable salt thereof; (b) a concentration-enhancing polymer; and (c) optionally one or more surfactants; wherein the compound has the structure shown as Formula I below. The composition raises HDL-cholesterol and lowers LDL-cholesterol.
La présente invention concerne une composition pharmaceutique comprenant (a) un composé d'inhibition de CETP, ou sel dérivé pharmaceutiquement acceptable, (b) un polymère d'amélioration de concentration et (c), en option, au moins un tensioactif, sachant que le composé a la structure affichée dans la Formule I ci-dessous. La composition augmente le cholestérol HDL et diminue le cholestérol LDL.
Geers Sarah
Lowinger Michael
Mckelvey Craig A.
Meyer Robert F.
Zhang Dina
Merck & Co. Inc.
Merck Sharp & Dohme Corp.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Polymer formulations of cetp inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polymer formulations of cetp inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polymer formulations of cetp inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1615570